pregnancy

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-07-12T15:30:24-04:00July 11th, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2021-03-29T10:51:11-04:00June 3rd, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

CBT for Depression During Pregnancy: Good for Moms, Good for Babies

Australian researchers have developed a cognitive behavioural therapy (CBT) treatment intervention for antenatal depression and anxiety.  Beating the Blues Before Birth, to be delivered as individual therapy, was adapted from a 12-session group intervention for [...]

By |2016-03-14T14:45:49-04:00March 14th, 2016|Cannabis, Depressive Disorders, Perinatal Substance Use, Psychiatric Disorders During Pregnancy|Comments Off on CBT for Depression During Pregnancy: Good for Moms, Good for Babies

New Research from the CWMH: Newer Antipsychotics and Pregnancy

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-03-28T13:02:50-04:00March 10th, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Newer Antipsychotics and Pregnancy

Venlafaxine and Duloxetine: Pooled Analysis Shows No Increase in Risk of Malformations

Women face difficult choices when deciding whether or not to continue psychiatric medications during pregnancy.  This choice can be especially difficult for women taking newer medications which lack adequate reproductive safety data.  While we have [...]

By |2015-11-03T13:37:33-04:00November 3rd, 2015|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Venlafaxine and Duloxetine: Pooled Analysis Shows No Increase in Risk of Malformations
Go to Top